Insights

Innovative Drug Delivery AcousticaBio specializes in transforming drug delivery formats through advanced microparticle technology and acoustophoretic platforms, offering opportunities to partner with biopharmaceutical companies seeking to improve patient compliance and reduce administration costs.

Expanding Therapeutic Range The company's versatile technology supports a broad spectrum of biologic products beyond monoclonal antibodies, presenting sales prospects across multiple therapeutic areas looking for innovative formulation solutions.

Market Expansion Potential By enabling self-administration of medications at home, AcousticaBio aligns with market trends favoring outpatient and patient-centered care, creating opportunities to collaborate with companies aiming to innovate in patient convenience and adherence.

Growing Biotechnology Segment Operating within the competitive biotech research industry with a revenue range of up to 10 million USD, the company is positioned for growth and can attract partnerships with larger firms seeking agile, innovative manufacturing solutions.

Technology-Driven Solutions Utilizing modern web and e-commerce tools, AcousticaBio demonstrates a forward-thinking approach that could appeal to digitally savvy partners and clients looking for cutting-edge manufacturing collaborations and joint development projects.

Similar companies to AcousticaBio

AcousticaBio Tech Stack

AcousticaBio uses 8 technology products and services including Webpack, Module Federation, Wix eCommerce, and more. Explore AcousticaBio's tech stack below.

  • Webpack
    Development
  • Module Federation
    Development
  • Wix eCommerce
    E-commerce
  • React
    Javascript Frameworks
  • Polyfill
    Javascript Libraries
  • WebsiteBuilder
    Page Builders
  • Priority Hints
    Performance
  • WordPress.com
    Platform As A Service

Media & News

AcousticaBio's Email Address Formats

AcousticaBio uses at least 1 format(s):
AcousticaBio Email FormatsExamplePercentage
First.Last@acoustica.bioJohn.Doe@acoustica.bio
50%
First.Last@acoustica.bioJohn.Doe@acoustica.bio
50%

Frequently Asked Questions

Where is AcousticaBio's headquarters located?

Minus sign iconPlus sign icon
AcousticaBio's main headquarters is located at 277 Broadway, 1st floor Cambridge, MA 02139, US. The company has employees across 1 continents, including North America.

What is AcousticaBio's official website and social media links?

Minus sign iconPlus sign icon
AcousticaBio's official website is acoustica.bio and has social profiles on LinkedInCrunchbase.

What is AcousticaBio's SIC code NAICS code?

Minus sign iconPlus sign icon
AcousticaBio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AcousticaBio have currently?

Minus sign iconPlus sign icon
As of October 2025, AcousticaBio has approximately 15 employees across 1 continents, including North America. Key team members include Ceo & Founder: D. F.Strategic Advisor: A. K.Scientific Advisor: G. B.. Explore AcousticaBio's employee directory with LeadIQ.

What industry does AcousticaBio belong to?

Minus sign iconPlus sign icon
AcousticaBio operates in the Biotechnology Research industry.

What technology does AcousticaBio use?

Minus sign iconPlus sign icon
AcousticaBio's tech stack includes WebpackModule FederationWix eCommerceReactPolyfillWebsiteBuilderPriority HintsWordPress.com.

What is AcousticaBio's email format?

Minus sign iconPlus sign icon
AcousticaBio's email format typically follows the pattern of First.Last@acoustica.bio. Find more AcousticaBio email formats with LeadIQ.

When was AcousticaBio founded?

Minus sign iconPlus sign icon
AcousticaBio was founded in 2021.

AcousticaBio

Biotechnology ResearchUnited States11-50 Employees

We are an advanced manufacturing company solving the greatest challenges in drug delivery for novel therapeutics. Today, millions of patients face the burden of frequent hospital visits, enduring painful, costly, and time-consuming intravenous injections to receive their life-saving medications. AcousticaBio transforms this process, making drug delivery as simple as receiving a routine flu shot.
 
Utilizing advanced microparticle technology and our Harvard-patented acoustophoretic platform, we convert intravenously delivered biologic products into highly concentrated, small-volume subcutaneous injections - all without the use of solvents or cumbersome post-processing. Our versatile technology extends beyond monoclonal antibodies, offering an unparalleled ability to formulate a wide range of materials across multiple therapeutic areas.
 
We are committed to collaborating with biopharmaceutical partners to advance their products, improve the quality of care, and enable patients to self-administer their life-saving medications from the comfort of their homes. Join us at AcousticaBio, where we value how work gets done just as much as what ultimately gets accomplished.

Section iconCompany Overview

Headquarters
277 Broadway, 1st floor Cambridge, MA 02139, US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2021
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $1M$10M

    AcousticaBio's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    AcousticaBio's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.